Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 641

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 641
---
,993 |   |
| Cash and cash equivalents as of beginning of the period                   |     |    10 |     |                   41,727 |   |     |     48,836 |   |
| Effect of exchange rate changes on cash and equivalents                   |     |       |     |                    2,729 |   |     |    (67,946 | ) |
| Cash and cash equivalents as of the end of the period                     |     |    10 |     |                    4,638 |   |     |      6,883 |   |

____________ (*)Non -cashtransaction:

| Operating activities                       |     |    |     |        |     |        |
| Terminated leases                          |     |    |     |      — |     | 28,840 |
| Financing activities                       |     |    |     |        |     |        |
| Capital increase from in kind contribution |     | 20 |     | 94,574 |     |      — |

The accompanying notes are an integral part of these Unaudited interim condensed Combined Financial Statements.

F-96 Notes to Unaudited Interim Condensed Combined Financial Statements (Amounts in US Dollars, except otherwise indicated) 1.General Information OmnigenicsAI Corp (“OmnigenicsAI” or the “Company”) is a company with limited liability, organized under the laws of the Cayman Islands, incorporated on January 9, 2024, originally under the name Heritas Cayco. The Company was incorporated for the purpose of making acquisitions and investments, with the objective of acting as the publicly traded holding company for its subsidiary. On March 18, 2024, Heritas Cayco formally changed its name to OmnigenicsAI Corp. On February 26, 2024, the Company underwent an intragroup reorganization pursuant to which Heritas Ltd., an exempted company organized under the laws of the Cayman Islands, contributed to OmnigenicsAI a wholly owned subsidiary of Heritas Ltd., all the issued and outstanding shares in its subsidiary, Heritas SAU (“Heritas Argentina”) in exchange for 30,000,000 newly issued shares, making Heritas SAU a wholly owned subsidiary. Together, OmnigenicsAI and its subsidiary, Heritas SAU, are referred to as the “Group.” On March 25, 2024, the Company entered into a Business Combination Agreement (“BCA”) with APx Acquisition Corp. I (“SPAC”).